Brompton Global Healthcare Inc & Gr ETF (HIG.TO)

9.26 +0.02  +0.22% TSX Nov 13, 11:43 Delayed 15m CAD
View Full Chart
Price Chart

Key Stats

Net Asset Value 9.239
Discount or Premium to NAV 0.02%
Turnover Ratio 61.66%
1 Year Fund Level Flows 857230.0

Performance & Returns

  Total Return (Price) Total Return (NAV) Cat. Total Return (NAV) % Rank in Cat. (NAV)
1M 2.43% 2.74% -- --
3M 0.11% 0.07% -- --
6M 7.85% 7.94% -- --
YTD 15.63% 14.99% -- --
1Y 8.46% 9.03% -- --
3Y -- 9.62% -- --
5Y -- -- -- --
10Y -- -- -- --
15Y -- -- -- --
20Y -- -- -- --
As of Nov. 12, 2019. Returns for periods of 1 year and above are annualized.

Asset Allocation

Type % Net % Long % Short
Cash 2.29% 98.69% 96.41%
Stock 97.71% 97.76% 0.05%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.00% 0.00% 0.00%
Other 0.00% 0.00% 0.00%
As of Oct. 31, 2019

Region Exposure

Americas 82.11%
North America 82.11%
Latin America 0.00%
Greater Europe 17.89%
United Kingdom 8.69%
Europe Developed 9.20%
Europe Emerging 0.00%
Africa/Middle East 0.00%
Greater Asia 0.00%
Japan 0.00%
Australasia 0.00%
Asia Developed 0.00%
Asia Emerging 0.00%
Market Classification
% Developed Markets 100.0%
% Emerging Markets --
As of Oct. 31, 2019. Region breakdown data is calculated by using the long position holdings of the portfolio.

Stock Sector Exposure

Basic Materials 0.00%
Communication Services 0.00%
Consumer Cyclical 0.00%
Consumer Defensive 0.00%
Energy 0.00%
Financial Services 0.00%
Healthcare 100.0%
Industrials 0.00%
Real Estate 0.00%
Technology 0.00%
Utilities 0.00%
As of Oct. 31, 2019

Stock Market Capitalization

Giant 39.79%
Large 53.36%
Medium 6.85%
Small 0.00%
Micro 0.00%
As of Oct. 31, 2019

Stock Style Exposure

Large Cap Value 6.59%
Large Cap Blend 37.12%
Large Cap Growth 49.44%
Mid Cap Value 0.00%
Mid Cap Blend 0.00%
Mid Cap Growth 6.85%
Small Cap Value 0.00%
Small Cap Blend 0.00%
Small Cap Growth 0.00%
As of Oct. 31, 2019
View More Holdings

Top 10 Holdings

Symbol Name % Weight Price % Chg
ZTS Zoetis Inc Class A 5.89% 116.53 -0.57%
EW Edwards Lifesciences Corp 5.74% 243.00 +1.52%
MDT Medtronic PLC 5.20% 109.00 +0.34%
TMO Thermo Fisher Scientific Inc 5.13% 299.90 +1.33%
SYK Stryker Corp 5.11% 201.77 +0.79%
STE Steris PLC 5.09% 145.53 -0.05%
AZN AstraZeneca PLC ADR 5.00% 47.11 +0.06%
ABT Abbott Laboratories 4.91% 84.01 -0.39%
PHG Royal Philips NV ADR 4.79% 43.98 +0.16%
BSX Boston Scientific Corp 4.77% 41.42 +0.49%
As of Oct. 31, 2019
Advertisement

Basic Info

Investment Strategy
The investment objectives of HIG are to provide holders of Units of HIG (the “HIG Unitholders”) with: (i) stable monthly cash distributions; (ii) the opportunity for capital appreciation; and (iii) lower overall volatility of portfolio returns than would otherwise be experienced by owning securities of Healthcare Companies (as defined herein) directly. HIG seeks to hedge substantially all of its exposure to foreign currencies back to the Canadian dollar.
General
Security Type Exchange-Traded Fund
Equity Style Large Cap/Growth
Fixed Income Style --
Broad Asset Class --
Broad Category Equity
Category Name Sector Equity
Prospectus Objective --
Fund Owner Firm Name Brompton Funds Limited
Benchmark Index
MSCI World Health Care GR 100.0%
Reports
One Page Report Download

Manager Info

Name Tenure
Not Disclosed 3.85 yrs

Net Fund Flows

1M 0.00
3M -494655.0
6M -21960.00
YTD 857230.0
1Y 857230.0
3Y --
5Y --
10Y --
As of Oct. 31, 2019

Risk Info

Beta (5Y) --
Max Drawdown (All) 16.45%
Historical Sharpe Ratio (10Y) --
Historical Sortino (All) 0.2767
30-Day Rolling Volatility 14.78%
Daily Value at Risk (VaR) 1% (All) 3.86%
Monthly Value at Risk (VaR) 1% (All) 10.61%

Fundamentals

Dividend Yield TTM (11-13-19) 6.48%
30-Day SEC Yield --
7-Day SEC Yield --
Weighted Average PE Ratio 34.22
Weighted Average Price to Sales Ratio 1.658
Weighted Average Price to Book Ratio 4.571
Weighted Median ROE 16.35%
Weighted Median ROA 6.50%
Forecasted Dividend Yield 1.21%
Forecasted PE Ratio 21.87
Forecasted Price to Sales Ratio 1.702
Forecasted Price to Book Ratio 4.145
Number of Holdings 48
As of Oct. 31, 2019

Growth Estimates

Forecasted 5 Yr Earnings Growth 10.84%
Forecasted Book Value Growth 6.04%
Forecasted Cash Flow Growth 4.91%
Forecasted Earnings Growth 32.17%
Forecasted Revenue Growth 6.76%
As of Oct. 31, 2019

Comparables

Edit

Attributes

Key Dates
Inception Date 9/24/2015
Termination Date
Last Annual Report Date 12/31/2018
Last Prospectus Date 3/26/2019
Attributes
Exchange Traded Share Yes
Exchange Traded Note No
Enhanced Index Fund No
Fixed Distribution Fund No
High-Net Worth Individual Fund No
Index Fund No
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
Socially Responsible Fund No
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP Yes
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.